COLL实时信号 | 通过Getagraph.com最大化利润

出售 104672 min ago

@ $32.43

发出时间: 14 Feb 2024 @ 22:32

回报率: 12.30%

上一信号: Feb 13 - 22:30

上一信号: 购买

回报率: -1.90 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	121 316
平均成交量	410 536
市值	1.16B
EPS	$0 ( 2024-02-22 )
下一个收益日期	( $1.500 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	28.23
ATR14	$0.0310 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-29	Smith Thomas B	Sell	995	Common Stock
2024-02-26	Dreyer Scott	Sell	9 336	Common Stock
2024-02-26	Dreyer Scott	Sell	664	Common Stock
2024-02-12	Tupper Colleen	Buy	30 856	Common Stock
2024-02-12	Tupper Colleen	Sell	16 868	Common Stock

INSIDER POWER
14.83
Last 100 transactions
Buy: 1 331 449 \| Sell: 1 023 987

音量相关性

長: 0.07 (neutral)

短: -0.21 (neutral)

Signal:(47.312) Neutral

Collegium Pharmaceutical 相关性

10 最正相关
BNIXU	0.971
AHCO	0.934
MDRX	0.929
CARA	0.928
RKDA	0.927
ATRA	0.925
CSSE	0.925
DISH	0.924
ETSY	0.923
UPLD	0.922

10 最负相关
MSDA	-0.922
MTEK	-0.914
BRIVU	-0.911
VLAT	-0.91
TIOAU	-0.909
ADAL	-0.908
PPYAU	-0.906
NVCN	-0.902
BNIX	-0.902
BRIV	-0.899

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Collegium Pharmaceutical 相关性 - 货币/商品

0.59
( weak )

0.60
( weak )

0.00
( neutral )

0.62
( weak )

-0.16
( neutral )

-0.56
( weak negative )

Collegium Pharmaceutical 财务报表

Annual	2023
营收:	$566.77M
毛利润:	$326.17M (57.55 %)
EPS:	$1.430

FY	2023
营收:	$566.77M
毛利润:	$326.17M (57.55 %)
EPS:	$1.430

FY	2022
营收:	$463.93M
毛利润:	$209.49M (45.15 %)
EPS:	$-0.740

FY	2021
营收:	$276.87M
毛利润:	$150.62M (54.40 %)
EPS:	$2.05

Financial Reports:

No articles found.

Collegium Pharmaceutical

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

实时更新： Collegium Pharmaceutical [COLL]

Upcoming Earnings Alert